Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00832884 · ClinicalTrials.gov registry record · Phase 4
The Safety of Intravenous Lacosamide
A Phase 4 study, sponsored by Le Bonheur Children's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT00832884 is a Phase 4 study that has completed, run by Le Bonheur Children's Hospital. The registered enrollment target is 40 participants.
The verdict
NCT00832884, a Phase 4 study, has completed, sponsored by Le Bonheur Children's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
To evaluate the safety of IV Lacosamide in children with partial-onset epilepsy, ages 4-35 years old, inclusive, who are either unable to take oral medication or require intravenous administration of IV Lacosamide.
Interventions
- DRUG Lacosamide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2010-03 |
| Est. Completion | 2012-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00832884
The ClinicalTrials.gov registry entry for NCT00832884 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Le Bonheur Children's Hospital, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lacosamide is the first listed.
NCT00832884 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00832884 about?
NCT00832884 is a clinical study titled "The Safety of Intravenous Lacosamide". To evaluate the safety of IV Lacosamide in children with partial-onset epilepsy, ages 4-35 years old, inclusive, who are either unable to take oral medication or require intravenous administration of IV Lacosamide.
What is the current status of trial NCT00832884?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2010-03. Estimated completion is 2012-11.
What interventions are being tested in trial NCT00832884?
The interventions under investigation include: Lacosamide (DRUG).
Who is sponsoring clinical trial NCT00832884?
This trial is sponsored by Le Bonheur Children's Hospital, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.